{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:08:10Z","timestamp":1793945290046,"version":"4.8.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Colorectal surgery is associated with moderate-to-severe postoperative complications in over 25% of patients, predominantly infections. Monocyte epigenetic alterations leading to immune tolerance could explain postoperative increased susceptibility to infections. This research explores whether changes in monocyte DNA accessibility contribute to postoperative innate immune dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Damage-associated molecular patterns (DAMPs) and ex vivo cytokine production capacity were measured in a randomized controlled trial (n = 100) in colorectal surgery patients, with additional exploratory subgroup proteomic (proximity extension assay; Olink) and epigenomic analyses (Assay for Transposase-Accessible Chromatin [ATAC sequencing]). Monocytes of healthy volunteers were used to study the effect of high-mobility group box 1 (HMGB1) and heat shock protein 70 (HSP70) on cytokine production capacity in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Plasma DAMPs were increased after surgery. HMGB1 showed a mean 235% increase from before- (preop) to the end of surgery (95% confidence interval [CI] [166 \u2013 305],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001) and 90% increase (95% CI [63\u2013118],\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .0004) preop to postoperative day 1 (POD1). HSP70 increased by a mean 12% from preop to the end of surgery (95% CI [3\u201321], not significant) and 30% to POD1 (95% CI [18\u201341],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001). Nuclear deoxyribonucleic acid (nDNA) increases by 66% (95% CI [40\u201392],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001) at the end of surgery and 94% on POD1 (95% CI [60\u2013127],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001). Mitochondrial DNA (mtDNA) increases by 370% at the end of surgery (95% CI [225\u2013515],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001) and by 503% on POD1 (95% CI [332\u2013673],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001). In vitro incubation of monocytes with HSP70 decreased cytokine production capacity of tumor necrosis factor (TNF) by 46% (95% CI [29\u201364],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001), IL-6 by 22% (95% CI [12\u201332],\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .0004) and IL-10 by 19% (95% CI [12\u201326],\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .0015). In vitro incubation with HMGB1 decreased cytokine production capacity of TNF by 34% (95% CI [3\u201365],\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .0003), interleukin 1\u03b2 (IL-1\u03b2) by 24% (95% CI [16\u201332],\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .0001), and IL-10 by 40% (95% CI [21\u201358],\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .0009). Analysis of the inflammatory proteome alongside epigenetic shifts in monocytes indicated significant changes in gene accessibility, particularly in inflammatory markers such as CXCL8 (IL-8), IL-6, and interferon-gamma (IFN-\u03b3). A significant enrichment of interferon regulatory factors (IRFs) was found in loci exhibiting decreased accessibility, whereas enrichment of activating protein-1 (AP-1) family motifs was found in loci with increased accessibility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>These findings illuminate the complex epigenetic modulation influencing monocytes\u2019 response to surgical stress, shedding light on potential biomarkers for immune dysregulation. Our results advocate for further research into the role of anesthesia in these molecular pathways and the development of personalized interventions to mitigate immune dysfunction after surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007297","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T13:01:59Z","timestamp":1729861319000},"page":"185-196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Postoperative Innate Immune Dysregulation, Proteomic, and Monocyte Epigenomic Changes After Colorectal Surgery: A Substudy of a Randomized Controlled Trial"],"prefix":"10.1213","volume":"140","author":[{"given":"Kim I.","family":"Albers-Warl\u00e9","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie S.","family":"Helder","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo A.","family":"Groh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Polat","sequence":"additional","affiliation":[{"name":"Department of Surgery, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo F.","family":"Panhuizen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M. J.","family":"Snoeck","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Kox","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"van Eijk","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"},{"name":"Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"},{"name":"Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Negishi","sequence":"additional","affiliation":[{"name":"Department of Biology, Radboudumc, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Mhlanga","sequence":"additional","affiliation":[{"name":"Department of Biology, Radboudumc, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Keijzer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Scheffer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel C.","family":"Warl\u00e9","sequence":"additional","affiliation":[{"name":"Department of Surgery, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"R1-20250224","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamasurg.2019.0995","article-title":"Association between use of enhanced recovery after surgery protocol and postoperative complications in colorectal surgery: the Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol (POWER) Study.","volume":"154","author":"Ripoll\u00e9s-Melchor","year":"2019","journal-title":"JAMA Surg"},{"key":"R2-20250224","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0036-1584501","article-title":"Postoperative complications: looking forward to a safer future.","volume":"29","author":"Tevis","year":"2016","journal-title":"Clin Colon Rectal Surg"},{"key":"R3-20250224","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s00595-021-02448-6","article-title":"The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery.","volume":"52","author":"Sato","year":"2022","journal-title":"Surg Today"},{"key":"R4-20250224","doi-asserted-by":"crossref","first-page":"807539","DOI":"10.3389\/fimmu.2022.807539","article-title":"Monitoring pre- and post-operative immune alterations in patients with locoregional colorectal cancer who underwent laparoscopy by single-cell mass cytometry.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"R5-20250224","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1097\/SLA.0000000000005491","article-title":"Quality of recovery and innate immune homeostasis in patients undergoing low- versus standard pressure pneumoperitoneum during laparoscopic colorectal surgery (RECOVER): a randomized controlled trial.","volume":"276","author":"Albers","year":"2022","journal-title":"Ann Surg"},{"key":"R6-20250224","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","article-title":"Trained immunity, tolerance, priming and differentiation: distinct immunological processes.","volume":"22","author":"Divangahi","year":"2021","journal-title":"Nat Immunol"},{"key":"R7-20250224","doi-asserted-by":"crossref","first-page":"662565","DOI":"10.3389\/fimmu.2021.662565","article-title":"Immune regulation in time and space: the role of local- and long-range genomic interactions in regulating immune responses.","volume":"12","author":"Devenish","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20250224","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fimmu.2018.00663","article-title":"Increased plasma levels of danger-associated molecular patterns are associated with immune suppression and postoperative infections in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.","volume":"9","author":"Leijte","year":"2018","journal-title":"Front Immunol"},{"key":"R9-20250224","doi-asserted-by":"crossref","first-page":"1031216","DOI":"10.3389\/fimmu.2022.1031216","article-title":"Monocyte response after colorectal surgery: a prospective cohort study.","volume":"13","author":"Edomskis","year":"2022","journal-title":"Front Immunol"},{"key":"R10-20250224","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/healthcare10081384","article-title":"Association of white blood cell subtypes and derived ratios with a mortality outcome in adult patients with polytrauma.","volume":"10","author":"Rau","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"R11-20250224","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s13063-020-04496-8","article-title":"The effect of low- versus normal-pressure pneumoperitoneum during laparoscopic colorectal surgery on the early quality of recovery with perioperative care according to the enhanced recovery principles (RECOVER): study protocol for a randomized controlled study.","volume":"21","author":"Albers","year":"2020","journal-title":"Trials"},{"key":"R12-20250224","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00134-015-4205-3","article-title":"Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients.","volume":"42","author":"Timmermans","year":"2016","journal-title":"Intensive Care Med"},{"key":"R13-20250224","article-title":"Olink target 96 inflammation."},{"key":"R14-20250224","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat Methods"},{"key":"R15-20250224","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/ATVBAHA.120.314212","article-title":"Trained immunity: long-term adaptation in innate immune responses.","volume":"41","author":"Tercan","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-20250224","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family.","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R17-20250224","doi-asserted-by":"crossref","first-page":"1104560","DOI":"10.3389\/fimmu.2023.1104560","article-title":"Damage-associated molecular patterns and sensing receptors based molecular subtypes in malignant pleural mesothelioma and implications for immunotherapy.","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"R18-20250224","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2012.00095","article-title":"The anti-inflammatory mechanisms of Hsp70.","volume":"3","author":"Borges","year":"2012","journal-title":"Front Immunol"},{"key":"R19-20250224","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1158\/0008-5472.CAN-13-2347","article-title":"HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.","volume":"74","author":"Parker","year":"2014","journal-title":"Cancer Res"},{"key":"R20-20250224","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/eji.201545497","article-title":"Innate immune memory: Implications for host responses to damage-associated molecular patterns.","volume":"46","author":"Cri\u0219an","year":"2016","journal-title":"Eur J Immunol"},{"key":"R21-20250224","doi-asserted-by":"crossref","first-page":"R662","DOI":"10.1186\/cc3826","article-title":"Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients.","volume":"9","author":"von Dossow","year":"2005","journal-title":"Crit Care"},{"key":"R22-20250224","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/ans.15791","article-title":"Risk factors of sepsis following pancreaticoduodenectomy based on inflammation markers and clinical characteristics.","volume":"90","author":"Zhang","year":"2020","journal-title":"ANZ J Surg"},{"key":"R23-20250224","doi-asserted-by":"crossref","first-page":"29820","DOI":"10.18632\/oncotarget.25661","article-title":"Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer.","volume":"9","author":"Vainer","year":"2018","journal-title":"Oncotarget"},{"key":"R24-20250224","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1038\/s41598-018-34054-x","article-title":"The roles of IL-17C in T cell-dependent and -independent inflammatory diseases. The roles of IL-17C in T cell-dependent and -independent inflammatory diseases.","volume":"8","author":"Yamaguchi","year":"2018","journal-title":"Sci Rep"},{"key":"R25-20250224","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.3390\/ijms21155186","article-title":"The CCL20-CCR6 axis in cancer progression.","volume":"21","author":"Kadomoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R26-20250224","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/08941939.2016.1231855","article-title":"Alarmins and clinical outcomes after major abdominal surgery: a prospective study.","volume":"30","author":"M\u00e1ca","year":"2017","journal-title":"J Invest Surg"},{"key":"R27-20250224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1699-0463.1993.tb00073.x","article-title":"Interferon-gamma and resistance to bacterial infections.","volume":"101","author":"Czarniecki","year":"1993","journal-title":"APMIS"},{"key":"R28-20250224","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.surg.2003.08.012","article-title":"Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism?","volume":"135","author":"Kahlke","year":"2004","journal-title":"Surgery"},{"key":"R29-20250224","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.pcl.2008.02.009","article-title":"Immunoparalysis and adverse outcomes from critical illness.","volume":"55","author":"Frazier","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"R30-20250224","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2019.01176","article-title":"Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease.","volume":"10","author":"Antonczyk","year":"2019","journal-title":"Front Immunol"},{"key":"R31-20250224","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors.","volume":"6","author":"Honda","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R32-20250224","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2017.02.006","article-title":"Interferon regulatory factor signaling in autoimmune disease.","volume":"98","author":"Matta","year":"2017","journal-title":"Cytokine"},{"key":"R33-20250224","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.2013.335","article-title":"IRF-1 responsiveness to IFN-\u03b3 predicts different cancer immune phenotypes.","volume":"109","author":"Murtas","year":"2013","journal-title":"Br J Cancer"},{"key":"R34-20250224","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis.","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R35-20250224","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1).","volume":"57","author":"Ye","year":"2014","journal-title":"J Med Chem"},{"key":"R36-20250224","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fimmu.2020.00796","article-title":"Concurrent immune suppression and hyperinflammation in patients with community-acquired pneumonia.","volume":"11","author":"Brands","year":"2020","journal-title":"Front Immunol"},{"key":"R37-20250224","doi-asserted-by":"crossref","first-page":"104590","DOI":"10.1016\/j.cellimm.2022.104590","article-title":"The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes.","volume":"379","author":"Yang","year":"2022","journal-title":"Cell Immunol"},{"key":"R38-20250224","doi-asserted-by":"crossref","first-page":"F67","DOI":"10.1152\/ajprenal.00412.2005","article-title":"Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells.","volume":"291","author":"Lee","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R39-20250224","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.intimp.2010.06.027","article-title":"Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E\u2082 production using intravenous anesthetic propofol.","volume":"10","author":"Inada","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"R40-20250224","doi-asserted-by":"crossref","first-page":"104153","DOI":"10.1016\/j.ebiom.2022.104153","article-title":"F. Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade.","volume":"82","author":"Masi\u00e1","year":"2022","journal-title":"EBioMed"},{"key":"R41-20250224","first-page":"217","article-title":"Ifn-Gamma as a major antiviral therapeutic for viral epidemics, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a clinically forgotten but potential antiviral cytokine and non-virus-specific antiviral as a new antiviral strategy.","volume":"5","author":"Noh","year":"2020","journal-title":"J Clin Rev Case Rep"},{"key":"R42-20250224","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1163\/156856005774423935","article-title":"AP-1 and colorectal cancer.","volume":"13","author":"Ashida","year":"2005","journal-title":"Inflammopharmacol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:14Z","timestamp":1786113014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007297","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}